from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2590/fadD9

LFCtreatmentdescriptionclass of inhibitor

-1.088

Amikacinug/mL Amikacintranslation

-1.112

Cap5-10ug/mL Capreomycintranslation

-1.016

Rox10-50 ug/mL Roxithromycintranslation

-0.907

SM2-5 ug/mL Streptomycintranslation

-1.138

Tet5-10 ug/mL Tetracyclinetranslation

-0.411

Rif0.2-5ug/mL Rifampicintranscription

-0.028

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.988

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.813

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.246

CPZ10-50 ug/mL Chlorpromazinerespiration

1.009

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.188

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.526

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.792

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.251

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.173

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.418

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.418

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.827

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.228

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.376

KCN5-20 ug/mL Potassium cyaniderespiration

1.098

NaN30.2-2 mM Sodium aziderespiration

-0.516

Nigericin50 uM Nigericinrespiration

-0.700

TRC10-150 ug/mL Triclosanrespiration

-0.616

TRZ10-25 ug/mL Thioridazinerespiration

0.622

Valinomycin0.5-10 uM Valinomycinrespiration

0.258

ZnSO42 mM ZnSO4respiration

0.809

menadione6-10 ug/mL Menadionerespiration

0.643

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.503

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.614

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.123

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.903

NRP_1Non-replicating persistence stage 1dosRassociated

-0.615

Amp0.2mg/mL AmpicillincellWall

-0.537

Cephalexin20-100 ug/mL CephalexincellWall

-0.478

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.098

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.318

EMB10-20 ug/mL EthambutolcellWall

-0.962

Eta12-40 ug/mL EthionamidecellWall

-1.096

INH0.2-0.4 ug/mL IsoniazidcellWall

0.763

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.368

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.682

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.434

BZA0.12 mg/mL BenzamidearomaticAmides

0.137

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.206

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.252

H2O24 mM hydrogen peroxideDNAdamaging

-0.207

Levo10 ug/mL LevofloxacinDNAdamaging

-0.440

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.267

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.721

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.851

UVUV-irradiationDNAdamaging

1.235

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.322

Antimycin12.5-50 ug/mL Antimycin A?

0.481

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.057

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.542

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.031

PA8240.2-2 ug/mL PA-824?

-1.255

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.214

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.300

Verapamil50 uM Verapamil?

0.705

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.045

methoxatin10-20 ug/mL Methoxatin?